RecruitingMetabolic Dysfunction-associated Steatotic Liver Disease
Advanced Fibrosis Detection for MASLD in Primary Care
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This proposal evaluates the implementation of a novel, non-interruptive, electronic health record alert for metabolic dysfunction-associated steatotic liver disease (MASLD) fibrosis risk assessment in primary care patients with MASLD using a stepped wedge, cluster randomized design. This work will generate generalizable data to dramatically enhance MASLD management in primary care.
Sponsor: Medical University of South Carolina
You may qualify if…
- ✓ Patients with a diagnosis code for MASLD
- ✓ Type 2 diabetes mellitus will
- ✓ 1\. All physicians, physician assistants, and nurse practitioners delivering primary care during the intervention phase of the study.
You may not qualify if…
- ✕ All patients with cirrhosis, complications of cirrhosis (e.g. portal hypertension, hepatic encephalopathy), hepatocellular carcinoma, or previous liver transplant will be excluded.
- ✕ pregnant women.
- ✕ Clinicians Clinicians will also be study participants, as we will be surveying them for feedback on the MASLD fibrosis risk assessment intervention. The MUSC primary care network at last count employed 122 clinicians across the 27 primary care practices.
- ✕ None
Where it's recruiting
South Carolina
Charleston
Source: ClinicalTrials.gov · NCT07159386 · last updated 2026-03-31